Filing Details
- Accession Number:
- 0001104659-22-089568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-11 21:46:45
- Reporting Period:
- 2022-08-09
- Accepted Time:
- 2022-08-11 21:46:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1657312 | Verona Pharma Plc | VRNA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1627642 | David Zaccardelli | 3 More London Riverside London X0 SE1 2RE | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2022-08-09 | 600,000 | $1.75 | 15,263,560 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 25, 2022.
- The price reported represents the sale price of the ADSs divided by eight (8).
- Consists of (i) 7,102,720 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share ofthe Issuer (which are represented by 887,840 ADSs); and (ii) 8,160,840 Ordinary Shares underlying 1,020,105 ADSs.